myNEO Therapeutics
PrivateLast Round
Accelerator
Jul 1, 2020
Total Funding Raised
$2.35M
Company Overview
myNEO Therapeutics is a biotechnology company that develops therapeutic cancer vaccines by applying artificial intelligence to identify novel cancer targets from the 'dark genome'.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
myNEO Therapeutics Comps
Public and private peers based on sector, stage, and business model.
myNEO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2020 | ||||
| Grant | Mar 2, 2020 | ||||
| Seed | Dec 27, 2018 | ||||
| Seed | Dec 27, 2018 |
myNEO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start it @KBC | Accelerator |
| VLAIO | Grant |
| Novalis Biotech | Seed |
| Endless Frontier Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2020
Received funding from Start it @KBC.
- Mar 2, 2020
$2.35M grant received from VLAIO
myNEO Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about myNEO Therapeutics's valuation, stock price, and market status.
